Private Equity

Updated:

Tririver Capital

Tririver Capital is a China-based investment banking firm focused on the bio and healthcare sector. The firm has made seven investments, including a Seed-II...

Tririver Capital logo

Tririver Capital

Tririver Capital is a China-based investment banking firm focused on the bio and healthcare sector. The firm has made seven investments, including a Seed-II investment in Anticancer Bioscience on October 14, 2021. Tririver Capital has one portfolio exit, BrightGene Bio-Medical Technology, which occurred on November 08, 2019.

General information

Firm type

Private Equity

Year founded

2008

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Frequently asked questions

What is Tririver Capital's investment focus?

Tririver Capital invests in early-stage Chinese companies, concentrating on seed and start-up rounds. The firm operates as a generalist venture investor based on available records. No specific sector concentrations or thesis statements have been disclosed publicly, making the focus broad by default until confirmed through direct engagement with the firm.

Who runs investment decisions at Tririver Capital?

Tririver Capital has not disclosed its leadership team, investment committee members, or any named managing partners through public records. The identities of the decision-makers behind the firm's venture investments are not available from open sources as of mid-2026. Allocators must obtain this information directly from the firm.

How large is Tririver Capital in terms of assets under management?

Tririver Capital does not publicly report assets under management, fund sizes, or total capital deployed. The scale of the firm remains undisclosed across all major databases and public filings. No third-party estimates have been published by any financial news outlet.

Does Tririver Capital participate in fund commitments or only direct deals?

The available public record only confirms direct early-stage equity investments at the seed and start-up level. Whether Tririver also participates as a limited partner in other venture funds or engages in fund-of-funds activity is not documented in any disclosed materials.

How is Tririver Capital structured legally?

Tririver Capital's legal structure has not been publicly detailed. Like many China-based venture firms, it likely operates through a combination of domestic RMB funds and offshore USD-denominated vehicles, but this cannot be confirmed without direct disclosure from the firm. The entity's registration in Shanghai suggests compliance with China's Asset Management Association requirements, but specific registrations are not verifiable from open sources.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Shanghai Private Equity profiles